Printable version: 
Fact sheet as of May 22, 2013
SEB Concept Biotechnology
The fund invests in equities and equity-related securities in the biotechnology sector across the world.
Fund manager:  Ulrika Bergman
SEB Investment Management AB
Employed in industry:  13 years
Investment Philosophy

The fund manager believes that the equity market is efficient in the long term. However, from a short term perspective, the market's players tend as a whole to react at different pace to new information. This inertia can create beneficial investment opportunities, and be best exploited when the fund management is based on a structural and quantitative process – which, in combination with a long-term approach and limitations of the fund's transaction costs, can create added-value.

Key Facts
keyvalue
Base CurrencyEUR
Share ClassC (EUR)
ISIN-codeLU0385485148
BenchmarkNasdaq Biotechn...
Year of launch2008
Value at launch (EUR)27.48
Legal StructureUCITS IV
Fund Management CompanySEB Asset Management S.A.
Morningstar Rating (3 years) 30 Apr 2013
Turnover Ratio*1.25
* 12 months rolling, last updated 30 Apr 2013
Dividend
The share class does not pay dividends; the return is reinvested
Costs
keyvalue
Management Fee1.50
Ongoing Charges*1.72
Entry FeeMax 1%
* The ongoing charges includes the management fee and constitutes payment for fund management, including marketing and distribution. The ongoing charges does not include transaction costs such as brokerage commissions on securities transactions.
Risk Measures*
keyvalue
Standard Deviation (Fund)13.0
Standard Deviation (Index)14.9
Tracking Error4.7
Sharpe Ratio1.6
Information Ratio-0.8
Alpha-3.7
Beta0.8
* 36 months rolling, last updated 30 Apr 2013
Investment Process

Investment universe

The fund invests globally in the biotechnology sector with focus on the US. The biotechnology sector is regarded as less sensitive to economic fluctuations than many other sectors, and the yield is dependent to a great deal on medical progress and scientific advances. Since the fund invests outside Sweden, the fund's asset value is affected by fluctuations of the Swedish krona in relation to other currencies. The fund has the possibility to use derivative instruments.

Investment team

The fund is managed by QPM (Quantitative Portfolio Management). The team works primarily with quantitative and rule-based management. The team is based in Stockholm Sweden.

Research

The fund only pursues exposure in liquid securities. A quantitative process forms the basis to distinguish and analyze biotechnology companies and identify those that have attractive growth potential, a good and sustainable financial position, and in general enjoy the confidence of the market. An analysis is also performed of each company's risk profile and how they individually affect the fund's aggregated risk structure.

Portfolio construction

When composing the portfolio, the manager focuses on selecting the most interesting equities within the biotechnology sector based on analysis methodology. Considerable weight is then placed on creating a well-balanced portfolio from a global perspective, and establishing a desired risk profile for the fund, while simultaneously limiting the related transaction costs.

Performance
Currency: EUR        |        NAV: 57.50 (5/22/2013)        |        AuM (M EUR) : 117.09 (4/30/2013)
SEB Concept Biotechnology (FundEUR)Nasdaq Biotechnology Index (Benchmark, )
 Fund EURBenchmark
Return % EURFundBenchmark
Accumulated since  
1 day-0.2-0.4
1 month6.45.2
3 months23.626.6
6 months28.632.6
1 year40.145.4
3 years103.3120.8
5 years--
Year to date31.435.0
Average annual growth  
3 years26.730.2
5 years--
CurrencyAdd benchmark
Download
Period
Open the calendar popup.
   
Open the calendar popup.
Largest Positions*
% of Total  
 % of Total
Gilead Sciences9.6
Amgen9.5
Celgene7.0
Regeneron Pharmaceuticals6.7
Alexion Pharmaceuticals6.2
iShares Nasdaq Biotechnology Index Fund 5.0
Biogen Idec4.9
Perrigo4.4
Mylan Lab4.0
Life Technologies Corp3.0
* Last updated 31 Mar 2013. Source: SEB
* Numbers are absolute, not relative
Geographic Allocation*
* Last updated 31 Mar 2013. Source: SEB
* Numbers are absolute, not relative
This presentation has been prepared by SEB and contains general information in relation to financial instruments marketed, sold or solicitated by SEB. Neither this document nor the products described in it are intended for distribution or sale in the United States or to US persons, and any such distribution may be unlawful. Although the information has been based on sources deemed by SEB to be reliable, SEB assumes no liability whatsoever for incorrect or missing information nor for any loss, damage or claim arising from the use of this presentation. Past performance is not indicative of future results, which may vary. The value of investments and the income derived from investments can go down as well as up. Future returns are not guaranteed, and a loss of principal may occur. If you or a fund invests in financial instruments denominated in a foreign currency, changes in currency exchange rates may affect the return on the investment. For funds with share classes which aims at hedging the returns from changes in currency exchange rates of the fund’s base currency, SEB makes no representation or warranty as to achieving the currency exchange rate hedge. Information on taxes (if any) has been based on in force as per the date of this presentation, and such rules may be subject to change thereafter. It should also be noted that information on tax have not been tailored on any individual circumstances of any individual unit holder and in order for an individual unit holder to understand the tax treatment of an investment the unit holder should obtain tax advice. The unit holder is fully responsible for any decision to invest in a fund, and this material may not constitute the sole basis for any such decision. Instead, any decision to invest in a fund should be based on the detailed information regarding the fund or the funds which is contained in their respective fact sheets, Key Investor Information Documents (“KIID”), fund regulations and full prospectuses, which materials can be obtained from www.seb.se/fonder. For funds which are not managed by SEB’s fund management companies, the said information may be obtained free of charge from investment advisers within SEB. SEB assumes that any unit holder, prior to making a decision to invest, carefully reads the detailed information regarding the fund or the funds which is contained in their respective fact sheets, KIID, fund regulations and full prospectuses. For investment advice tailored to individual circumstances, you are kindly requested to contact your investment adviser within SEB.
Thursday, May 23, 2013 7:54:34 PM